Biselyngbyaside

ID: ALA4207081

Chembl Id: CHEMBL4207081

PubChem CID: 44140287

Max Phase: Preclinical

Molecular Formula: C34H52O9

Molecular Weight: 604.78

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  C/C=C/C/C(C)=C\[C@H]1C/C=C/C=C/C[C@H](C)/C=C(\C)[C@@H](OC)C/C=C/[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](OC)[C@H]2O)CC(=O)O1

Standard InChI:  InChI=1S/C34H52O9/c1-7-8-14-24(3)20-26-16-12-10-9-11-15-23(2)19-25(4)28(39-5)18-13-17-27(21-30(36)41-26)42-34-32(38)33(40-6)31(37)29(22-35)43-34/h7-13,17,19-20,23,26-29,31-35,37-38H,14-16,18,21-22H2,1-6H3/b8-7+,11-9+,12-10+,17-13+,24-20-,25-19+/t23-,26+,27+,28-,29+,31+,32+,33-,34+/m0/s1

Standard InChI Key:  QLNOFWPLTFNJPW-CMAVNLJPSA-N

Alternative Forms

1. Parent:

   

   ALA4207081

   (4s,5e,8s,9e,11s,13e,15e,18r)-8-Methoxy-9,11-Dimethyl-18-[(1z,4e)-2-Methylhexa-1,4-Dien-1-Yl]-2-Oxooxacyclooctadeca-5,9,13,15-Tetraen-4-Yl 3-O-Methyl-Beta-D-Glucopyranoside

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 604.78

Molecular Weight (Monoisotopic): 604.3611

AlogP: 4.49

#Rotatable Bonds: 8

Polar Surface Area: 123.91

Molecular Species: NEUTRAL

HBA: 9

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 9

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 12.28

CX Basic pKa: ┄

CX LogP: 4.61

CX LogD: 4.61

Aromatic Rings: ┄

Heavy Atoms: 43

QED Weighted: 0.27

Np Likeness Score: 2.59

References

1. Sato E, Morita M, Ogawa H, Iwatsuki M, Hokari R, Ishiyama A, Ōmura S, Iwasaki A, Suenaga K..  (2018)  Design, synthesis and anti-malarial activities of synthetic analogs of biselyngbyolide B, a Ca²⁺ pump inhibitor from marine cyanobacteria.,  28  (3): [PMID:29292225] [10.1016/j.bmcl.2017.12.050]

2. Peterková L, Kmoníčková E, Ruml T, Rimpelová S..  (2020)  Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.,  63  (5): [PMID:32030976] [10.1021/acs.jmedchem.9b01509]

3. Govindarajan M..  (2018)  Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics.,  143  [PMID:29126728] [10.1016/j.ejmech.2017.10.015]

Source

Source(1):

• Scientific Literature